CBLL

Ceribell Inc

23.45

Aug 26 • 3:59 PM ET -0.50 (-2.09%)

23.45

Aftermarket • 5:00 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Small NASD

Peers: INSP NVCR GKOS BSX EW MDT TFX BAX BDX RMD

| Held by: IWM VTI IWO VXF FFSM VTWO SCHA IWC LFSC VHT

Scroll to Statements

Index	RUT
Market Cap	899.97M
Enterprise Value	792.62M
Income	-66.00M
Sales	101.96M
Book/sh	3.36
Cash/sh	3.37
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	327
IPO	Oct 11, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	8.83
P/B	6.99
P/C	6.96
P/FCF	-
EV/EBITDA	-
EV/Sales	7.77
Quick Ratio	8.66
Current Ratio	9.05
Debt/Eq	0.17
LT Debt/Eq	0.16
Option/Short	Yes / Yes

EPS (ttm)	-1.76
EPS next Y	-1.56
EPS next Q	-0.51
EPS this Y	-35.12%
EPS next Y	20.90%
EPS next 5Y	4.38%
EPS past 3/5Y	-10.19% -
Sales past 3/5Y	50.90% -
EPS Y/Y TTM	-28.13%
Sales Y/Y TTM	31.70%
EPS Q/Q	-34.77%
Sales Q/Q	32.54%
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-8.23% 3.01%

Insider Own	33.86%
Insider Trans	-4.32%
Inst Own	68.72%
Inst Trans	4.37%
ROA	-35.29%
ROE	-43.93%
ROIC	-44.28%
Gross Margin	88.90%
Oper. Margin	-68.62%
Profit Margin	-64.73%
SMA20	8.83%
SMA50	18.17%
SMA200	21.21%
Trades

Shs Outstand	38.22M
Shs Float	25.38M
Short Float	8.28%
Short Ratio	5.53
Short Interest	2.10M
52W High	25.33 -7.42%
52W Low	10.85 116.13%
Volatility	2.93% 4.53%
ATR (14)	0.93
RSI (14)	65.39
Beta	0.93
Rel Volume	0.59
Avg Volume	379.95K
Volume	225,744

Perf Week	-5.79%
Perf Month	31.52%
Perf Quarter	25.40%
Perf Half Y	23.75%
Perf YTD	6.93%
Perf Year	104.62%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	27.29
Prev Close	23.95
Price	23.45
Change %	-2.09%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Initiated	Raymond James	Strong Buy	$19
Jun-24-25	Initiated	BTIG Research	Buy	$30
Apr-04-25	Initiated	Ladenburg Thalmann	Buy	$32
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	TD Cowen	Buy	$31
Nov-05-24	Initiated	JP Morgan	Overweight	$32
Nov-05-24	Initiated	Canaccord Genuity	Buy	$30
Nov-05-24	Initiated	BofA Securities	Buy	$32

Aug-11-26 01:02AM	CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ... (GuruFocus.com) +10.41%
Aug-10-26 09:50PM	CeriBell, Inc. Q2 2026 Earnings Call Summary (Moby)
04:05PM	Ceribell Reports Second Quarter 2026 Financial Results (GlobeNewswire)
07:00AM	Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review (GlobeNewswire)
Aug-07-26 09:19AM	What To Expect From CeriBell Inc (CBLL) Q2 2026 Earnings (GuruFocus.com)
09:43AM	Loading…
Aug-04-26 09:43AM	CeriBell Inc (CBLL) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-03-26 08:45AM	CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System (InvestorsHub)
07:00AM	Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System (GlobeNewswire)
Jul-29-26 07:00AM	Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe (GlobeNewswire)
Jul-28-26 04:05PM	Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-20-26 04:05PM	Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026 (GlobeNewswire)
Jun-08-26 07:00AM	Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes (GlobeNewswire)
May-20-26 04:05PM	Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +6.72%
May-12-26 08:30AM	CeriBell, Inc. Q1 2026 Earnings Call Summary (Moby) -16.50%
03:07AM	CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ... (GuruFocus.com)
04:05PM	Loading…
May-11-26 04:05PM	Ceribell Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-08-26 09:17AM	What To Expect From CeriBell Inc (CBLL) Q1 2026 Earnings (GuruFocus.com)
Apr-29-26 04:05PM	Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference (GlobeNewswire) -7.45%
Apr-20-26 04:05PM	Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 (GlobeNewswire)
Mar-07-26 11:15AM	CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium (MarketBeat)
10:23AM	CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot (MarketBeat)
Mar-02-26 10:23AM	Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord (Insider Monkey)
Feb-25-26 12:03AM	CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... (GuruFocus.com)
Feb-24-26 10:06PM	CeriBell Q4 Earnings Call Highlights (MarketBeat)
09:55PM	CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
08:03PM	CeriBell, Inc. Q4 2025 Earnings Call Summary (Moby)
04:05PM	Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-23-26 07:26AM	CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-18-26 04:05PM	Ceribell to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-10-26 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
09:21AM	Loading…
Jan-14-26 09:21AM	CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion (MarketBeat)
Jan-06-26 12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
Jan-05-26 08:00AM	Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution (GlobeNewswire)
Dec-30-25 04:05PM	Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire)
Dec-09-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution (GlobeNewswire)
Nov-24-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates (GlobeNewswire)
Nov-19-25 04:05PM	Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-25 12:06AM	CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +7.88%
Nov-04-25 06:05PM	CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 10:00AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.24%
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-21-25 04:05PM	Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire) +7.04%
Sep-22-25 08:00AM	Medtech Leader Erica Rogers Joins Ceribell Board of Directors (GlobeNewswire)
Aug-13-25 12:08PM	J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT (Insider Monkey)
Aug-05-25 04:05PM	Ceribell Reports Second Quarter 2025 Financial Results (GlobeNewswire) -15.25%
Jul-29-25 04:05PM	Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-22-25 04:05PM	Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-07-25 04:42PM	Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware (GlobeNewswire) -9.14%
Jun-20-25 09:11AM	AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape (PR Newswire)
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive)
May-20-25 04:05PM	Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:43AM	CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com) -6.61%
May-08-25 04:05PM	Ceribell Reports First Quarter 2025 Financial Results (GlobeNewswire) +6.81%
Apr-30-25 04:05PM	Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
08:00AM	Ceribell Receives FedRAMP High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems (GlobeNewswire)
Apr-24-25 04:05PM	Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 05:00AM	Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
Apr-16-25 10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
Apr-15-25 08:00AM	FDA Clears Ceribell's Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older (GlobeNewswire)
Apr-07-25 01:04PM	CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It Today (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Feb-26-25 02:15AM	CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com)
Feb-25-25 04:05PM	Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference (GlobeNewswire)
Feb-11-25 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (GlobeNewswire)
Dec-23-24 04:05PM	Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-19-24 08:00AM	Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing (GlobeNewswire)
07:01AM	Meet the biophysicist whose seizure-detection company is using AI to get a better read on peoples brains (FastCompany)
Nov-13-24 11:55PM	Ceribell, Inc. Reports Strong Q3 2024 Growth (TipRanks)
Nov-12-24 04:05PM	Ceribell Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs (GlobeNewswire)
Nov-07-24 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-06-24 06:31AM	Ceribell initiated with a Buy at BofA on differentiated AI algorithm (TipRanks)
Oct-29-24 04:05PM	Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 (PR Newswire)
Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Co-FounderDr. Xingjuan Chao Ph.D.

Ph.D.Dr. Josef Parvizi M.D.

Chief Financial OfficerMr. Scott Blumberg

Chief Technology OfficerDr. Raymond Woo Ph.D.

Senior Vice President of OperationsMr. Dan Rogy

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manni Joseph S.	Chief Revenue Officer	Aug 21 '26	Sale	24.02	1,361	32,691	55,956	Aug 25 07:29 PM
Foehr David	Senior VP, Finance and PAO	Aug 21 '26	Sale	24.02	993	23,852	36,758	Aug 25 07:27 PM
Foehr David	Senior VP, Finance and PAO	Aug 24 '26	Sale	23.95	859	20,573	35,899	Aug 25 07:27 PM
Woo Raymond	Chief Technology Officer	Aug 21 '26	Sale	24.02	1,979	47,536	194,729	Aug 25 07:25 PM
Blumberg Scott	Chief Financial Officer	Aug 21 '26	Sale	24.02	1,521	36,534	146,600	Aug 25 07:24 PM
Chao Xingjuan	President and CEO	Aug 21 '26	Sale	24.02	6,068	145,753	781,731	Aug 25 07:20 PM
Foehr David	Officer	Aug 24 '26	Proposed Sale	23.95	859	20,573		Aug 24 09:39 AM
Blumberg Scott	Officer	Aug 21 '26	Proposed Sale	24.02	1,521	36,537		Aug 21 05:05 PM
Foehr David	Officer	Aug 21 '26	Proposed Sale	24.02	993	23,854		Aug 21 05:04 PM
Woo Raymond	Officer	Aug 21 '26	Proposed Sale	24.02	1,979	47,539		Aug 21 04:54 PM
Manni Joseph S.	Officer	Aug 21 '26	Proposed Sale	24.02	1,361	32,694		Aug 21 04:52 PM
Chao Xingjuan	Officer	Aug 21 '26	Proposed Sale	24.02	6,068	145,764		Aug 21 04:51 PM
Blumberg Scott	Chief Financial Officer	Aug 19 '26	Option Exercise	8.54	33,512	286,245	181,633	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 18 '26	Option Exercise	6.13	990	6,066	149,111	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 19 '26	Sale	25.03	33,512	838,805	148,121	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 18 '26	Sale	25.00	990	24,750	148,121	Aug 20 08:55 PM
Chao Xingjuan	President and CEO	Aug 19 '26	Sale	25.03	31,415	786,317	787,799	Aug 20 06:51 PM
Chao Xingjuan	President and CEO	Aug 18 '26	Sale	25.00	2,199	54,975	819,214	Aug 20 06:51 PM
Blumberg Scott	Officer	Aug 19 '26	Proposed Sale	25.03	33,512	838,820		Aug 19 04:29 PM
Chao Xingjuan	Officer	Aug 19 '26	Proposed Sale	25.03	31,415	786,364		Aug 19 04:29 PM
Chao Xingjuan	Officer	Aug 18 '26	Proposed Sale	25.00	2,199	54,975		Aug 18 04:57 PM
Blumberg Scott	Officer	Aug 18 '26	Proposed Sale	25.00	990	24,750		Aug 18 04:15 PM
Chao Xingjuan	President and CEO	Aug 13 '26	Option Exercise	3.31	33,096	109,385	821,413	Aug 17 06:27 PM
Taylor Joseph Michael	Director	Aug 13 '26	Sale	23.40	13,095	306,423	48,478	Aug 14 02:37 PM
Taylor Joseph Michael	Director	Aug 13 '26	Proposed Sale	22.91	13,095	300,000		Aug 13 10:29 AM
Chao Xingjuan	President and CEO	Aug 03 '26	Option Exercise	4.70	25,000	117,500	827,317	Aug 05 03:31 PM
Chao Xingjuan	President and CEO	Aug 03 '26	Sale	18.32	39,000	714,480	788,317	Aug 05 03:31 PM
Chao Xingjuan	Officer	Aug 03 '26	Proposed Sale	18.00	39,000	702,000		Aug 03 10:02 AM
Chao Xingjuan	President and CEO	Jul 07 '26	Option Exercise	4.70	25,000	117,500	825,871	Jul 09 12:34 PM
Chao Xingjuan	President and CEO	Jul 07 '26	Sale	19.90	39,000	776,100	802,317	Jul 09 12:34 PM
Chao Xingjuan	Officer	Jul 07 '26	Proposed Sale	20.00	39,000	780,000		Jul 07 10:01 AM
BURKE WILLIAM W	Director	Jun 30 '26	Sale	19.84	2,207	43,787	23,022	Jul 02 12:08 PM
TPG GP A, LLC	Former 10% Owner	Jun 26 '26	Sale	20.12	202,368	4,071,705	3,765,054	Jun 30 04:29 PM
BURKE WILLIAM W	Director	Jun 30 '26	Proposed Sale	19.84	2,207	43,787		Jun 30 09:49 AM
Taylor Joseph Michael	Director	Jun 11 '26	Sale	18.41	5,500	101,255	61,573	Jun 15 01:48 PM
Taylor Joseph Michael	Director	Jun 11 '26	Proposed Sale	18.41	5,500	101,255		Jun 11 10:15 AM
Chao Xingjuan	President and CEO	Jun 08 '26	Option Exercise	4.70	25,000	117,500	839,871	Jun 10 12:53 PM
Chao Xingjuan	President and CEO	Jun 08 '26	Sale	18.33	39,000	714,870	816,317	Jun 10 12:53 PM
Chao Xingjuan	Officer	Jun 08 '26	Proposed Sale	18.36	39,000	716,040		Jun 08 02:23 PM
Manni Joseph S.	Chief Revenue Officer	May 21 '26	Sale	18.00	1,378	24,804	56,291	May 26 04:22 PM
Foehr David	Senior VP, Finance and PAO	May 21 '26	Sale	18.00	987	17,766	38,613	May 26 04:18 PM
Foehr David	Senior VP, Finance and PAO	May 22 '26	Sale	18.80	862	16,206	37,751	May 26 04:18 PM
Woo Raymond	Chief Technology Officer	May 21 '26	Sale	18.00	1,966	35,388	195,682	May 26 04:17 PM
Blumberg Scott	Chief Financial Officer	May 21 '26	Sale	18.00	1,387	24,966	147,683	May 26 04:16 PM
Chao Xingjuan	President and CEO	May 21 '26	Sale	18.00	6,030	108,540	830,317	May 26 04:15 PM
Foehr David	Officer	May 22 '26	Proposed Sale	18.80	862	16,206		May 22 10:29 AM
Foehr David	Officer	May 21 '26	Proposed Sale	18.00	987	17,762		May 21 04:10 PM
Woo Raymond	Officer	May 21 '26	Proposed Sale	18.00	1,966	35,380		May 21 04:04 PM
Chao Xingjuan	Officer	May 21 '26	Proposed Sale	18.00	6,030	108,515		May 21 03:53 PM
Manni Joseph S.	Officer	May 21 '26	Proposed Sale	18.00	1,378	24,798		May 21 03:51 PM
Blumberg Scott	Officer	May 21 '26	Proposed Sale	18.00	1,387	24,960		May 21 03:15 PM
BURKE WILLIAM W	Director	May 08 '26	Proposed Sale	26.01	4,823	125,446		May 08 10:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Option Exercise	4.70	25,000	117,500	859,901	May 07 11:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Sale	20.10	39,000	783,973	836,347	May 07 11:09 AM
Chao Xingjuan	Officer	May 05 '26	Proposed Sale	20.10	39,000	784,000		May 05 04:25 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Option Exercise	4.37	11,104	48,575	204,259	May 04 07:05 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Sale	20.44	11,104	226,928	197,648	May 04 07:05 PM
Woo Raymond	Officer	May 01 '26	Proposed Sale	20.16	11,104	223,857		May 01 03:10 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Option Exercise	4.70	25,000	117,500	873,901	Apr 08 12:47 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Sale	18.40	39,000	717,600	850,347	Apr 08 12:47 PM
Chao Xingjuan	Officer	Apr 06 '26	Proposed Sale	18.40	39,000	717,551		Apr 06 04:27 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Option Exercise	4.37	11,112	48,605	173,527	Apr 03 01:55 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Sale	18.56	11,112	206,244	166,912	Apr 03 01:55 PM
Woo Raymond	Officer	Apr 01 '26	Proposed Sale	18.56	11,112	206,261		Apr 01 04:21 PM
Chao Xingjuan	President and CEO	Mar 25 '26	Option Exercise	2.72	55,628	151,397	766,792	Mar 27 12:25 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Option Exercise	4.70	4,560	21,432	20,953	Mar 05 02:22 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Sale	17.80	4,560	81,168	17,550	Mar 05 02:22 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Sale	17.80	827	14,721	18,749	Mar 05 02:20 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Option Exercise	4.70	25,000	117,500	734,718	Mar 05 02:18 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Sale	17.45	39,000	680,564	711,164	Mar 05 02:18 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Option Exercise	4.37	11,112	48,605	173,527	Mar 04 01:28 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Sale	18.25	8,087	147,602	166,912	Mar 04 01:28 PM
Chao Xingjuan	Officer	Mar 03 '26	Proposed Sale	17.80	39,000	694,200		Mar 03 01:46 PM
Foehr David	Officer	Mar 03 '26	Proposed Sale	17.80	4,560	81,168		Mar 03 12:17 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Proposed Sale	17.80	827	14,721		Mar 03 11:37 AM
Woo Raymond	Officer	Mar 02 '26	Proposed Sale	18.14	11,112	201,572		Mar 02 11:56 AM
Foehr David	Senior VP, Finance and PAO	Feb 24 '26	Sale	19.98	781	15,604	17,550	Feb 25 04:46 PM
Foehr David	Senior VP, Finance and PAO	Feb 23 '26	Sale	19.79	569	11,261	18,331	Feb 25 04:46 PM
Manni Joseph S.	Chief Revenue Officer	Feb 23 '26	Sale	19.79	768	15,199	26,933	Feb 25 04:46 PM
Woo Raymond	Chief Technology Officer	Feb 23 '26	Sale	19.79	705	13,952	166,912	Feb 25 04:45 PM
Blumberg Scott	Chief Financial Officer	Feb 23 '26	Sale	19.79	808	15,990	118,334	Feb 25 04:45 PM
Chao Xingjuan	President and CEO	Feb 23 '26	Sale	19.79	2,084	41,242	725,164	Feb 25 04:44 PM
Foehr David	Officer	Feb 24 '26	Proposed Sale	19.98	781	15,604		Feb 24 11:35 AM
Woo Raymond	Officer	Feb 23 '26	Proposed Sale	19.79	705	13,955		Feb 23 04:46 PM
Chao Xingjuan	Officer	Feb 23 '26	Proposed Sale	19.79	2,084	41,252		Feb 23 04:45 PM
Manni Joseph S.	Officer	Feb 23 '26	Proposed Sale	19.79	768	15,202		Feb 23 04:36 PM
Blumberg Scott	Officer	Feb 23 '26	Proposed Sale	19.79	808	15,994		Feb 23 04:34 PM
Foehr David	Officer	Feb 23 '26	Proposed Sale	19.79	569	11,263		Feb 23 04:26 PM
Parvizi Josef	Director	Feb 19 '26	Sale	20.27	16,714	338,793	722,652	Feb 23 12:07 PM
Parvizi Josef	Director	Feb 18 '26	Sale	20.00	6,986	139,720	739,366	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 17 '26	Sale	20.00	1,300	26,000	746,352	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 19 '26	Proposed Sale	20.27	16,714	338,754		Feb 19 04:08 PM
Parvizi Josef	Director	Feb 18 '26	Proposed Sale	20.01	6,986	139,770		Feb 18 04:20 PM
Parvizi Josef	Director	Feb 17 '26	Proposed Sale	20.00	1,300	26,000		Feb 17 04:37 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Option Exercise	4.70	25,000	117,500	750,802	Feb 06 03:51 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Sale	20.16	39,000	786,240	727,248	Feb 06 03:51 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Option Exercise	4.70	5,556	26,113	22,303	Feb 05 12:54 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Sale	20.00	5,556	111,120	18,900	Feb 05 12:54 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Option Exercise	4.37	11,112	48,605	174,232	Feb 04 04:01 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Sale	20.55	11,112	228,375	167,617	Feb 04 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBLL

Ceribell Inc

Upgrade your Finviz experience